New program aims to catch liver disease before it's too late

NCT ID NCT07031089

Recruiting now Knowledge-focused Sponsor: University Hospital, Grenoble Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at a program where family doctors work with a hospital to find liver scarring (fibrosis) early in people at risk. About 150 adults with a high FIB-4 score will get a special liver scan (Fibroscan). The goal is to see if those with scarring get the right follow-up care, like seeing a liver specialist. This is not a treatment study but a way to improve how we detect and manage liver disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIVER FIBROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cirrhosis of liver fibrotic liver disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LIVER FIBROSIS

Contacts and locations

Locations

Communauté Professionnelle Territoriale de Santé Sud Est Grenoblois
NOT_YET_RECRUITING

Grenoble, France
Grenoble Alpes University Hospital
RECRUITING

Grenoble, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.